The Spanish Agency for Medicines and Health Products (Aemps) has warned about the withdrawal of several batches of the drug Duloxetine Sandoz, which is used to treat anxiety and depression. They have made the decision after detecting "an impurity above its established limit".
The affected batches are R77, R975, S0024 and S0595 of Duloxetine Sandox 30 mg; lots R1214, R76 and S0482, 60mg; and R1073, R133 and S0199, 60 mg but in 56 capsule versions.
It is a medicine manufactured by Lesvi laboratories. According to the Aemps, they have withdrawn from the market all the units distributed from the affected batches and have carried out the return to the laboratory through the usual channels, although this "quality defect does not pose a serious or vital risk to the patient", they clarify.
According to The Trust Project criteria
Learn more
- Health